Organisation
Nuclear Medicine & Molecular Imaging
Division
Tomographic evaluation of tracer distribution (PET, SPECT). - Medical Imaging: acquition, reconstruction PET and SPECT. - Metabolic Imaging in acute and chronic heart disease. - Metabolic Imaging in oncology and inflammation - Neuroactivation, protein deposit and receptor studies of the brain. - Radio immunotherapy. - Molecular imaging - Brain imaging. - Image registration (PET, SPECT, MRI, CT).
Current researchers
1 - 10 of 25 results
- Koen Van Laere (Responsible)
- Niloefar Ahmadi Bidakhvidi (Member)
- Kristof Baete (Member)
- Charles Carron (Member)
- Dayana Castillo Seoane (Member)
- Christopher Cawthorne (Member)
- Sofie Celen (Member)
- Christophe Deroose (Member)
- Masoud ElhamiAsl (Member)
- Prodromos Gavriilidis (Member)
Projects
1 - 10 of 123
- Prospective clinical diagnostic performance of the novel fibroblast imaging tracer 18F-AlF-FAPI-74 versus standard of care 18F-FDG PET/CT in inflammatory disorders and fever/inflammation of unknown origin.From16 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development and preclinical evaluation of diagnostic and therapeutic radiopharmaceuticals for pancreatic cancerFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral imaging in the diagnosis, management and prognosis of possible non-convulsive status epilepticus.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A whole-body physiologically based pharmacokinetic model for personalized 161Tb-PRRTFrom1 Oct 2023 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral imaging in the diagnosis, management and prognosis of possible non-convulsive status epilepticusFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral functional (FDG-PET, arterial spin imaging and CT perfusion), structural and spectral imaging in the diagnosis, management and prognosis of status epilepticus: a prospective study in patients with the ictal-interictal continuum and normal EEG.From1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption
Publications
1 - 10 of 1555
- Assessment of Chemotherapy-Induced Organ Damage with Ga-68 Labeled Duramycin(2020)
Authors: Anne Rix, Natascha Ingrid Drude, Anna Mrugalla, Ferhan Baskaya, Koon Yan Pak, Brian Gray, Hans-Jurgen Kaise, Rene Hany Tolba, Eva Fiegle, Wiltrud Lederle, et al.
Pages: 623 - 633 - Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies(2020)
Authors: Ali Modabber, Daniel Schick, Stephan C Moehlhenrich, Felix Mottaghy, Frederik A Verburg, Frank Hoelzle, Marcus Gerressen
- Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET(2008)
Authors: Sigrid Stroobants, Luc Mortelmans
Pages: 1074 - 1080 - Functional segmentation of occupancy images improves precision of EC50 images(2022)
Authors: Bart de Laat
Pages: 302 - 303 - Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [(18)F]FDG PET(2010)
Authors: Marijke De Saint-Hubert, Sigrid Stroobants, Gregor Verhoef, Jan Balzarini, Luc Mortelmans, Felix Mottaghy
Pages: 1688 - 1695 - Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer(2010)
Authors: Felix Mottaghy
Pages: 1668 - 1675 - Caffeine and Cognition in Functional Magnetic Resonance Imaging(2010)
Authors: Felix Mottaghy
Pages: S71 - S84 - SUCCESSFUL PALLIATIVE PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR IMPENDING COMPRESSION OF VENA CAVA DUE TO UNRESECTABLE LIVER METASTASIS OF NEUROENDOCRINE TUMOR(2019)
Authors: Bahar Ataeinia, Christina Loberg, Hanna Kravets, Mohsen Beheshti, Dirk von Mallek, Felix Mottaghy, Alexander Heinzel
Pages: 273 - 276 - Natural history of surgically treated high-risk prostate cancer(2015)
Authors: Alberto Briganti, Robert Jeffrey Karnes, Giorgio Gandaglia, Martin Spahn, Paolo Gontero, Lorenzo Tosco, Burkhard Kneitz, Felix K H Chun, Emanuele Zaffuto, Maxine Sun, et al.
Pages: 163.e7 - 163.e13 - MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence (vol 53, pg 796, 2012)(2012)
Authors: Yannick Berker, Jochen Franke, Andre Salomon, Moritz Palmowski, Henk CW Donker, Yavuz Temur, Felix Mottaghy, Christiane Kuhl, David Izquierdo-Garcia, Zahi A Fayad, et al.
Pages: 1496 - 1496